1-4 of 4
Chanchala Kaddi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Doses of Factor Concentrates and Bypassing Agents to Treat Breakthrough Bleeds in Patients with Hemophilia A and B on Fitusiran Antithrombin-Based Dosing Regimen: ATLAS-OLE

Steven W. Pipe, Kaan Kavakli, Tadashi Matsushita, Huyen Tran, Bulent Zulfikar, Laurel Menapace, Marja Puurunen, Wenruo Hu, Yuqian Shen, Chanchala Kaddi, Vanessa Salinas
Journal: Blood
Blood (2024) 144 (Supplement 1): 128.
https://doi.org/10.1182/blood-2024-206946
Published: 2024
Journal Articles

Mechanistic Modeling to Support Hemostatic Equivalency of Antithrombin Lowering in People with Hemophilia A or B

Randolph Leiser, Chanchala Kaddi, Mengdi Tao, Ane Salvador, Ekta Seth Chhabra, Susana Zaph
Journal: Blood
Blood (2024) 144 (Supplement 1): 2590.
https://doi.org/10.1182/blood-2024-199185
Published: 2024
Journal Articles

Development of a Quantitative Systems Pharmacology Model to Explore Hemostatic Equivalency of Antithrombin Lowering

Chanchala Kaddi, Mengdi Tao, Randolph Leiser, Ane Salvador, Sravya Kattula, Pratik Bhagunde, Viridiana Cano Garcia, Ekta Seth Chhabra, Susana Zaph
Journal: Blood
Blood (2022) 140 (Supplement 1): 5606–5607.
https://doi.org/10.1182/blood-2022-169043
Published: 2022
Journal Articles

Quantitative Systems Pharmacology Model of Sickle Cell Disease and Response to Gene Editing Therapy to Support Clinical Development of SAR445136 (BIVV003)

Chanchala Kaddi, Danielle Holz, Mengdi Tao, Isobelle Galeon, David Reiner, Pablo Rendo, Susana Zaph
Journal: Blood
Blood (2021) 138 (Supplement 1): 1860.
https://doi.org/10.1182/blood-2021-147330
Published: 2021